LobbyingHypoparathyroidism Association lobbying by quarter
Hypoparathyroidism Association's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Pharmacy.
Hypoparathyroidism Association
- Latest quarter
- $0
- Q2 2026 · 1 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
Policy issues the reports name
- Pharmacy15 reports
A report that names several issues counts once for each.
Who was lobbied
- Food & Drug Administration (FDA)15 reports
- Health & Human Services, Dept of (HHS)15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rubicon Advisors | $0 | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Rubicon Advisors | Under $5,000 |
| 04/23for Q1 | Rubicon Advisors | Under $5,000 |
| 01/18for Q4 2025 | Rubicon Advisors | Under $5,000 |
| 25/10/21for Q3 2025 | Rubicon Advisors | Under $5,000 |
| 25/07/19for Q2 2025 | Rubicon Advisors | Under $5,000 |
| 25/04/21for Q1 2025 | Rubicon Advisors | Under $5,000 |
| 25/01/21for Q4 2024 | Rubicon Advisors | Under $5,000 |
| 24/10/22for Q3 2024 | Rubicon Advisors | Under $5,000 |
| 24/07/21for Q2 2024 | Rubicon Advisors | Under $5,000 |
| 24/05/08for Q1 2024 | Rubicon Advisors | Under $5,000 |
| 24/01/25for Q4 2023 | Rubicon Advisors | Under $5,000 |
| 23/10/22for Q3 2023 | Rubicon Advisors | Under $5,000 |
| 23/07/23for Q2 2023 | Rubicon Advisors | Under $5,000 |
| 23/04/20for Q1 2023 | Rubicon Advisors | Under $5,000 |
| 23/01/16for Q4 2022 | Rubicon Advisors | Under $5,000 |